ELF4
ETS-related transcription factor Elf-4
Also known as: ELF4_HUMAN, ELFR, MEF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99607
- Gene
- ELF4
- Ensembl
- ENSG00000102034
- Chromosome
- X
- Canonical length
- 663 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The protein encoded by this gene is a transcriptional activator that binds and activates the promoters of the CSF2, IL3, IL8, and PRF1 genes. The encoded protein is involved in natural killer cell development and function, innate immunity, and induction of cell cycle arrest in naive CD8+ cells. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
663 residues, UniProt reviewed canonical sequence.
>Q99607|ELF4
1 MAITLQPSDL IFEFASNGMD DDIHQLEDPS VFPAVIVEQV PYPDLLHLYS GLELDDVHNG
61 IITDGTLCMT QDQILEGSFL LTDDNEATSH TMSTAEVLLN MESPSDILDE KQIFSTSEML
121 PDSDPAPAVT LPNYLFPASE PDALNRAGDT SDQEGHSLEE KASREESAKK TGKSKKRIRK
181 TKGNRSTSPV TDPSIPIRKK SKDGKGSTIY LWEFLLALLQ DRNTCPKYIK WTQREKGIFK
241 LVDSKAVSKL WGKQKNKPDM NYETMGRALR YYYQRGILAK VEGQRLVYQF KEMPKDLVVI
301 EDEDESSEAT AAPPQASTAS VASASTTRRT SSRVSSRSAP QGKGSSSWEK PKIQHVGLQP
361 SASLELGPSL DEEIPTTSTM LVSPAEGQVK LTKAVSASSV PSNIHLGVAP VGSGSALTLQ
421 TIPLTTVLTN GPPASTTAPT QLVLQSVPAA STFKDTFTLQ ASFPLNASFQ DSQVAAPGAP
481 LILSGLPQLL AGANRPTNPA PPTVTGAGPA GPSSQPPGTV IAAFIRTSGT TAAPRVKEGP
541 LRSSSYVQGM VTGAPMEGLL VPEETLRELL RDQAHLQPLP TQVVSRGSHN PSLLGNQTLS
601 PPSRPTVGLT PVAELELSSG SGSLLMAEPS VTTSGSLLTR SPTPAPFSPF NPTSLIKMEP
661 HDILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELF4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 50 nTPM
- placenta: 22 nTPM
- stomach: 19 nTPM
- thymus: 18 nTPM
- urinary bladder: 18 nTPM
- lymph node: 17 nTPM
Single-cell type
- neutrophils: 131 nCPM
- urothelial cells: 113 nCPM
- neutrophil progenitors: 81 nCPM
- epicardial cells: 77 nCPM
- extravillous trophoblasts: 62 nCPM
- foveolar cells: 58 nCPM
Immune cell
- intermediate monocyte: 7.4 nTPM
- gdT-cell: 7 nTPM
- neutrophil: 6.8 nTPM
- NK-cell: 6.6 nTPM
- memory CD8 T-cell: 6 nTPM
- eosinophil: 5.8 nTPM
Brain region
- medulla oblongata: 14 nTPM
- white matter: 14 nTPM
- thalamus: 14 nTPM
- cerebral cortex: 13 nTPM
- cerebellum: 12 nTPM
- midbrain: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ELF4.
Disease | AllUniProt
Conditions ELF4 is implicated in, by any mechanism.
- Autoinflammatory syndrome, familial, X-linked, Behcet-like 2 (AIFBL2) MIM:301074
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 170 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autoinflammatory syndrome, familial, X-linked, Behcet-like 2
- Thyroid cancer, nonmedullary, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- natural killer cell proliferation
- negative regulation of inflammatory response
- negative regulation of interleukin-1 beta production
- negative regulation of interleukin-6 production
- negative regulation of tumor necrosis factor production
- NK T cell proliferation
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ELF4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELF4 as an antibody target. Whether an autoantibody or antibody against ELF4 could matter depends on whether native ELF4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELF4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELF4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...